Abram Nunn
Physician Assistant · Sacramento, CANPI 1952730020
Payments from drug & device makers
Across 165 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$762
- Otsuka America Pharmaceutical, Inc.$685
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$571
- Teva Pharmaceuticals USA, Inc.$431
- Alkermes, Inc.$411
- Neurocrine Biosciences, Inc.$238
- plus $543 from 7 others
What the payments were for
- Food & beverage$3,42394%
- Education$2206%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $762 |
| Otsuka America Pharmaceutical, Inc. | 37 | $685 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 28 | $571 |
| Teva Pharmaceuticals USA, Inc. | 22 | $431 |
| Alkermes, Inc. | 20 | $411 |
| Neurocrine Biosciences, Inc. | 9 | $238 |
| E.r. Squibb & Sons, L.L.C. | 8 | $172 |
| Axsome Therapeutics, Inc. | 5 | $123 |
| Indivior Inc. | 5 | $120 |
| Lundbeck LLC | 2 | $64 |
| Merck | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
How this compares
$3,642 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 68 | $107,083 |
| Invega SustennaPaliperidone Palmitate | 32 | $87,768 |
| Abilify MaintenaAripiprazole | 30 | $81,087 |
| Lurasidone Hcl | 24 | $21,114 |
| Aripiprazole | 84 | $11,101 |
| Quetiapine Fumarate | 127 | $9,424 |
| Clozapine | 94 | $6,840 |
| Bupropion XlBupropion Hcl | 92 | $2,543 |
| Ziprasidone Hcl | 16 | $2,261 |
| Divalproex Sodium ErDivalproex Sodium | 65 | $1,730 |
| Hydroxyzine Hcl | 56 | $1,224 |
| Divalproex Sodium | 43 | $1,087 |
| Olanzapine | 42 | $708 |
| Mirtazapine | 12 | $467 |
| Gabapentin | 52 | $362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $571 | $107,08368 claims |
| Johnson & JohnsonInvega Sustenna | $762 | $87,76832 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $685 | $81,08730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Sacramento
- Franklin ClineSacramento$458K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.